Login
Enter your username or email address
Enter the password that accompanies your username.

Request new password

Home

Progress in Mind SEA

  • Topics
    • Depression
    • Migraine
    • Schizophrenia
    • Parkinson's Disease
    • Alzheimer's Disease
    • Bipolar Disease
    • Anxiety
  • Congress Highlights
    • EAN 2023
    • WPA 2022
    • EPA 2022
    • APA 2022
    • EAN 2022
    • WCN 2021
    • ECNP 2021
    • IHC 2021
    • AAN 2021
    • AHS 2021
    • EPA 2021
    • WPA 2021
    • CINP 2021
  • BRAIN MASTER
  • ASK THE EXPERTS
  • About

Articles

Pathology
  • Alzheimer's Disease 12 Nov, 2021 Read Time: 3 mins
    Congress highlights

    Active immunotherapy targets early stage Alzheimer’s disease

    Active immunotherapies have been designed to activate an immune response in the human body of...
  • Alzheimer's Disease 12 Nov, 2021 Read Time: 2 mins
    Article

    How beneficial is cholinesterase inhibition and for whom?

    New evidence suggests that cholinesterase inhibition in prodromal Alzheimer’s disease (AD) reduces...
  • Anxiety, Depression 19 Jul, 2018 Read Time: 6 mins
    Article

    New understanding of the gut microbiome may be the key to many diseases and pave the way for new therapies

    The role of the gut microbiome in a range of psychiatric disorders, including depression and anxiety,...

Progress in Mind South East Asia

HCP Access Verification Required

To gain access, please provide details to verify you are a healthcare professional.

Register Login

If you are not located in South East Asia click here.

Brought to you by

Lundbeck

© 2022 Lundbeck SEA

PROGRESS IN MIND SOUTH EAST ASIA

Disclaimer and privacy statement

Cookies

About

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue